The weakening of the epidermal barrier function in AD is associated with the downregulation of barrier-associated molecules such as filaggrin (FLG), loricrin (LOR), and involucrin (IVL) [4], which are coordinated by various barrier proteins such as FLG and LOR via sequential cross-linking. This evidence concerns the gene FLG and Alzheimer disease.